Alveolusbio
8 employees on LinkedIn · 1 known investors
Find your way into Alveolusbio
672 people in our graph share verified history with the Alveolusbio team — schools, employers, funds. One of them is your warm intro.
Marcunlockedknows Gaurav Mehta · together at Massachusetts Institute of Technology (overlapped)
knows the team · via Massachusetts Institute of Technology
×2knows the team · via MIT Sloan School of Management
×2knows the team · via MIT Media Lab
knows the team · via Ethicon, Inc., a Johnson & Johnson Company
×4knows the team · via Texas Christian University
Alveolus Bio develops inhaled biotherapeutics for chronic and infectious lung diseases, using a platform that delivers targeted bacteria to the lungs to treat conditions such as idiopathic pulmonary fibrosis, NCFBE, and COPD. It serves patients with chronic and infectious respiratory conditions in the biotechnology and pharmaceutical space.
Founders & leadership
CV
C Vivek LalinFounder & CSO
AG
Amit GaggarinChief Medical Officer
GM
Gaurav MehtainCEOGaurav Mehta is an MIT graduate with experience in global operations, having co-managed a $160M automated manufacturing facility at Alcon, and has founded ventures in healthcare technology that raised over $10M in funding.
Investors · 1
Competitors · 6
by search overlap
Talus Bio7 shared keywordsTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Alveo5 shared keywordsAlveo Technologies makes a palm-sized molecular diagnostic analyzer with preloaded test cartridges that deliver on-site pathogen results in under an hour, with results sent to a smartphone. It targets point-of-need infectious disease detection, including avian influenza testing for poultry farms and workers.
Nautilus Biotechnology5 shared keywordsNautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.
Precision BioSciences5 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Alume Biosciences5 shared keywordsAlume Biosciences develops nerve illumination technology for surgery, including bevonescein (ALM-488), an injectable peptide that makes nerves glow to help surgeons identify and preserve them during procedures such as head-and-neck and prostate surgery. The drug candidate is in Phase 3 clinical trials, with a planned FDA New Drug Application submission in 2026.
TELA Bio4 shared keywordsOffers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
Companies competing with Alveolusbio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Alveolusbio do?
- Alveolus Bio develops inhaled biotherapeutics for chronic and infectious lung diseases, using a platform that delivers targeted bacteria to the lungs to treat conditions such as idiopathic pulmonary fibrosis, NCFBE, and COPD. It serves patients with chronic and infectious respiratory conditions in the biotechnology and pharmaceutical space.
- Who founded Alveolusbio?
- Alveolusbio was founded by C Vivek Lal.
- Who are Alveolusbio's investors?
- Alveolusbio's investors include Lumira Ventures.